Cromos Pharma began managing clinical research in Georgia in 2013. Since then, our Tbilisi-based operation has grown exponentially, managing numerous successful regional and global studies in a broad range of therapeutic areas.
|Lightning fast approval process. Georgia's regulatory approval process takes on average about two months.|
|Georgia's rapidly growing study-related workforce is well experienced in international, ICH GCP-compliant clinical trials.|
|Georgia's investment in the healthcare sector over the last decade has increased the number of medical facilities and in-patient beds.|
Most hospitals are well-equipped, and the staff is eager to participate in clinical research.
|Good recruitment potential due to an ethnically diverse population with treatment- naive patients in a range of therapeutic areas.|
Georgia's costs of clinical research are much lower than the US or Western Europe.
|Economic and political reforms have made Georgia an attractive and welcoming destination for international companies seeking to do business there.|
|Investigators and their patients are highly motivated to participate in trials as a way of accessing novel therapies not yet available through the national health system.|
Fourteen different therapeutic areas including:
Heart Disease, brain diseases, central nervous system diseases, neurological diseases, RNA infections and other viruses.
Georgia boasts an impressively rapid regulatory study approval process (<2 months from submission to study start). This rapid startup timeline, combined with a pool of skilled and professional medical staff, full compliance with ICH GCP standards and a solid reputation for producing high quality results make Georgia a very attractive prospect for sponsors.
Tuesday 1 December marked World AIDS Day 2020. Although throughout this year our focus has been on the coronavirus pandemic, World AIDS Day is an opportunity to reflect on another pandemic where a virus passed from animals to humans with devastating consequences. To date 77 million people worldwide have been infected with HIV. In spite of innovative new treatments 35 million people have died from the virus.
If you missed the live webinar “Where in the world should I locate my pivotal clinical trial?” you can now watch the recording by clicking here. The webinar hosted by the Society of Physician Entrepreneurs (SoPE) and Workforce Genetics features Cromos Pharma's CEO Vlad Bogin, M.D, FACP.